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University of Edinburgh, Edinburgh, United Kingdom
Abstract When mammalian cells detect a viral infection, they initiate a type I interferon (IFNs)
response as part of their innate immune system. This antiviral mechanism is conserved in virtually all
cell types, except for embryonic stem cells (ESCs) and oocytes which are intrinsically incapable of
producing IFNs. Despite the importance of the IFN response to fight viral infections, the
mechanisms regulating this pathway during pluripotency are still unknown. Here we show that, in
the absence of miRNAs, ESCs acquire an active IFN response. Proteomic analysis identified MAVS,
a central component of the IFN pathway, to be actively silenced by miRNAs and responsible for
suppressing IFN expression in ESCs. Furthermore, we show that knocking out a single miRNA, miR-
673, restores the antiviral response in ESCs through MAVS regulation. Our findings suggest that
the interaction between miR-673 and MAVS acts as a switch to suppress the antiviral IFN during
pluripotency and present genetic approaches to enhance their antiviral immunity.
DOI: https://doi.org/10.7554/eLife.44171.001
Introduction
Type I interferons (IFN) are crucial cytokines of the innate antiviral response. Although showing great
variation, most mammalian cell types are capable of synthesizing type I IFNs in response to invading
viruses and other pathogens. Once type I IFNs are secreted, they activate the JAK-STAT pathway
and production of interferon-stimulated genes (ISGs) in both the infected and neighbouring cells to
induce an antiviral state (Ivashkiv and Donlin, 2015). Two major signalling pathways are involved in
IFN production in the context of viral infections. The dsRNA sensors RIG-I and MDA5 initiate a sig-
nalling cascade that signals through the central mitochondrial-associated factor MAVS, ultimately
activating Ifnb1 transcription. The cGAS/STING pathway is activated upon detection of viral or other
foreign DNA molecules and uses a distinct signalling pathway involving the endoplasmic reticulum
associated STING protein (Chan and Gack, 2016).
Despite its crucial function in fighting pathogens, pluripotent mammalian cells do not exhibit an
IFN response. Both mouse and human embryonic stem cells (ESCs) (Wang et al., 2013; Chen et al.,
2010) as well as embryonic carcinoma cells (Burke et al., 1978) fail to produce IFNs, suggesting
that this function is acquired during differentiation. The rationale for silencing this response is not
fully understood but it has been proposed that in their natural setting, ESCs are protected from viral
infections by the trophoblast, which forms the outer layer of the blastocyst (Delorme-Axford et al.,
2014). ESCs exhibit a mild response to exogenous IFNs, suggesting that during embryonic develop-
ment, maternal IFN could have protective properties (Hong and Carmichael, 2013; Wang et al.,
2014). In mouse ESCs, a Dicer-dependent RNA interference (RNAi) mechanism, reminiscent to that
of plants and insects, is suggested to function as an alternative antiviral mechanism (Maillard et al.,
2013). And in humans, ESCs intrinsically express high levels of a subgroup of ISGs in the absence of
infection, bypassing the need for an antiviral IFN response (Wu et al., 2018; Wu et al., 2012). All
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these suggest that different antiviral pathways are employed depending on the differentiation status
of the cell. Silencing of the IFN response during pluripotency may also be essential to avoid aberrant
IFN production in response to retrotransposons and endogenous retroviral derived dsRNA, which
are highly expressed during the early stages of embryonic development and oocytes (Ahmad et al.,
2018; Grow et al., 2015;Macia et al., 2015; Peaston et al., 2004; Macfarlan et al., 2012). Further-
more, exposing cells to exogenous IFN induces differentiation and an anti-proliferative state, which
would have catastrophic consequences during very early embryonic development (Borden et al.,
1982; Hertzog et al., 1994).
All these observations support a model in which cells gain the ability to produce IFNs during dif-
ferentiation. One particular class of regulatory factors that are essential for the successful differentia-
tion of ESCs are miRNAs (Greve et al., 2013). These type of small RNAs originate from long
precursor RNA molecules, which undergo two consecutive processing steps, one in the nucleus by
the Microprocessor complex, followed by a DICER-mediated processing in the cytoplasm
(Treiber et al., 2018). The Microprocessor complex is composed of the dsRNA binding protein
DGCR8 and the RNase III DROSHA which are both essential for mature miRNA production
(Gregory et al., 2004; Lee et al., 2003). In addition, mammalian DICER is also essential for produc-
tion of siRNAs (Bernstein et al., 2001). The genetic ablation of Dgcr8 or Dicer in mice blocks ESCs
differentiation suggesting that miRNAs are an essential factor for this, as these are the common sub-
strates for the two RNA processing factors (Wang et al., 2007; Kanellopoulou et al., 2005).
In this study, we show that miRNAs are responsible for suppressing the IFN response during pluri-
potency, specifically to immunostimulatory RNAs. We found that miRNA-deficient ESCs acquire an
IFN-proficient state, are able to synthesize IFN-b and mount a functional antiviral response. Our
results show that miRNAs specifically downregulate MAVS (mitochondrial antiviral signalling protein),
an essential and central protein in the IFN response pathway. In agreement, ESCs with increased
MAVS expression or knock-out of the MAVS-regulating miRNA miR-673, resulted in an increased
IFN production and antiviral response. Our results support a model where the MAVS-miR-673
eLife digest Living cells are under constant attack from disease-causing agents, such as viruses
and bacteria. As a result, they have evolved various protective mechanisms to fight off these agents.
One of the most important ways that an animal cell protects itself from infection is through the
interferon response, which warns the cell of approaching viruses, prompting it to prepare to defend
itself. Virtually all healthy cells have an active interferon response, except for stem cells, which have
switched off this defensive mechanism, for unknown reasons. This makes stem cells more susceptible
to infections.
Stem cells are specialized cells that play an essential role in developing the early embryo. The
two defining characteristics of these cells – their ability to divide indefinitely, and develop into all cell
types – offers great therapeutic potential, as they can be used to ‘replace’ damaged cells and
tissues. However, without an interferon response, stem cells are likely to become infected when
moved into a new environment, counteracting their therapeutic benefits. Now, Witteveldt et al.
investigate how stem cells turn off this viral defence mechanism, and whether turning it back on will
affect their ability to divide and form new tissues.
Using stem cells taken from the embryos of mice, Witteveldt et al. found that the interferon
response is turned off by specific small molecules of RNA. These small RNA molecules block a
protein in the pathway that recognizes viruses and activates a defence. Genetically engineering stem
cells to be deficient in these small RNA molecules led to an increased resistance to viral infections.
Importantly, modifying stem cells in this manner had no obvious impact on the characteristic traits
that give stem cells their therapeutic potential.
Temporarily increasing the interferon response of stem cells as they are moved into a new
environment could potentially make stem cell treatments more effective. However, more work is
needed to investigate whether the same approach can be applied to human cells, and determine
what negative effects may be associated with turning on the interferon response.
DOI: https://doi.org/10.7554/eLife.44171.002
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interaction acts as a switch to suppress the IFN response and consequently virus susceptibility during
pluripotency.
Results
ESCs fail to express IFN-b in response to viral DNA/RNA
There are two major pathways for sensing intracellular viral infections and consequent activation of
the IFN response in cells. One senses dsRNA, usually originating from RNA viruses, with MAVS as a
central factor, and the second senses dsDNA, from DNA- and retroviruses signalling through STING
(McFadden et al., 2017). It has been shown that mouse ESCs do not produce type I IFNs in
response to poly(I:C) transfection, a synthetic analogue of dsRNA classically used to mimic viral RNA
replication intermediates (Wang et al., 2013). In contrast, it is still unknown how mouse ESCs
respond to immunostimulatory DNA. To study this, two different mouse ESC cell lines (ESC1 and
ESC2) were transfected with poly(I:C) and G3-YSD, an HIV-derived DNA that stimulates the cGAS/
STING pathway (Herzner et al., 2015). As controls, NIH3T3 fibroblasts and BV-2 microglial cells
were included. As expected, the transfection of poly(I:C) did not result in Ifnb1 expression in both
ESC lines (Figure 1A). ESCs also failed to activate Ifnb1 expression upon G3-YSD transfection, sug-
gesting that the cGAS/STING pathway was also inactive (Figure 1B). Similarly, NIH3T3 cells, which
have also been previously shown to have a defect in this specific pathway (Cheng et al., 2018), did
not express Ifnb1 in response to G3-YSD (Figure 1B). These same cell lines were infected with the
(+) ssRNA virus TMEV (Theiler’s Murine Encephalomyelitis Virus) and showed that ESCs are at least
30 times more sensitive than NIH3T3 and BV-2 cells, which correlates with the ability of these cell
lines to induce Ifnb1mRNA expression (Figure 1C).
The ability of cells to express IFN in response to viruses or immunogenic nucleic acids is assumed
to be acquired during differentiation. To test this model, we in vitro differentiated both ESC lines
with retinoic acid and determined their ability to respond to poly(I:C). Briefly, embryoid bodies were
generated by a hanging droplet method for 48 hr before being cultured in the presence of retinoic
acid for 2 or 10 days. Samples from each of these time points were analysed for expression of pluri-
potency and differentiation markers. The pluripotency markers Nanog and Pou5f1 (Oct4) showed a
rapid decrease in mRNA expression during differentiation in both the cell lines (Figure 1—figure
supplement 1A), whereas differentiation markers Neurog2, Gata6 and Gata4 showed a gradual
increase (Figure 1—figure supplement 1B) confirming successful differentiation of the ESCs. Next,
we compared the ability of ESCs (day 0) and retinoic-acid differentiated cells after 10 days (day 10)
to express Ifnb1 mRNA in response to poly(I:C), and confirmed that differentiated cells acquired the
ability to synthesize Ifnb1 to similar levels to the positive control cell line, BV-2 (Figure 1D).
Dicer-deficient ESCs acquire an active IFN response
Given the relevance of RNAi as an antiviral mechanism in mouse ESCs (Maillard et al., 2013), we
next asked if ESCs, in the absence of the central factor for RNAi, ICER, would be more susceptible
to RNA viruses. Unexpectedly, Dicer-/- ESCs were more resistant to viruses compared to their wild-
type counterparts (previously named ESC2) (Figure 2A, left). Similar results were obtained using the
(-) ssRNA virus, Influenza A (IAV) (Figure 2A, right). Importantly, mammalian Dicer has a dual func-
tion, being essential for both siRNA and miRNA biogenesis. To determine whether these differences
in viral susceptibility were due to the activity of Dicer on siRNA or miRNA production, we compared
Dicer-/- cells with ESCs lacking the essential nuclear factor for miRNA biogenesis, Dgcr8. The
absence of Dgcr8 also decreased TMEV and IAV viral susceptibility, suggesting that miRNAs are
responsible for suppressing the antiviral response in ESCs (Figure 2A). Interestingly, Dgcr8-/- cells
were more resistant to virus infection than Dicer-/- cells, which supports a dual function for DICER by
also acting as a direct antiviral factor targeting viral transcripts for degradation by RNAi. To rule out
the possibility of morphological differences influencing viral susceptibility, we performed a virus
binding and entry assay which showed no differences (Figure 2—figure supplement 1).
Even though ESCs lack an IFN response, we wondered whether the differential resistance to viral
infections were the result of abnormal IFN activation due to the absence of miRNAs. To test this
hypothesis, we transfected the dsRNA analogue, poly(I:C) and the immunogenic G3-YSD DNA in
Dgcr8 or Dicer deficient mESCs, and quantified Ifnb1 expression by RT-qPCR and ELISA. ESCs
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lacking miRNAs (Dgcr8-/- or Dicer-/-) were able to respond to the dsRNA analogue, poly(I:C) and
express Ifnb1 mRNA and protein in a dose dependent manner (Figure 2B and Figure 2—figure sup-
plement 2A–C), whereas no significant response was observed with immunostimulatory DNA
(Figure 2B). These results show there is a correlation between viral susceptibility and the ability of
miRNA-deficient ESCs to express IFN-b, and suggest that miRNAs are responsible for silencing the
IFN response to dsRNA. To further establish the involvement of IFN expression in these
immunogenic DNA
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Figure 1. ESCs lack IFN response and are more susceptible to viral infection. (a) Quantification of Ifnb1 expression in ESCs and the somatic mouse cell
lines NIH3T3 and BV-2 after transfection with the dsRNA analogue poly(I:C). Data show the average (n = 3)±s.e.m, (*) p-value<0.05 by t-test. (b)
Quantification of Ifnb1 expression after activation of the cGAS response by Y-DNA (G3-YSD) in the same cells lines as (a). Data show the average (n = 3,
except for ESC2, n = 2)±s.e.m, (*) p-value<0.05 by t-test. (c) Susceptibility (TCID50/ml) of same cell lines as used in (a) to TMEV infection. (d)
Quantification of Ifnb1 expression in pluripotent and differentiated ESCs after activation with poly(I:C). Data show the average (n = 3) fold change over
mock treated cells,±s.d. (*) p-value<0.05 by t-test.
DOI: https://doi.org/10.7554/eLife.44171.003
The following figure supplement is available for figure 1:
Figure supplement 1. Retinoic acid differentiation of ESCs.
DOI: https://doi.org/10.7554/eLife.44171.004
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Figure 2. MiRNAs regulate IFN response. (a) (left) Susceptibility (TCID50/ml) of miRNA deficient cells (Dgcr8
-/-, Dicer-/-) and wild-type parental cells
(Dgcr8+/+(ESC1), Dicer+/+(ESC2)) to TMEV infection, higher values represent higher susceptibility (n = 4, p-value<0.05, t-test). (right) Quantification of
Influenza A replication after infection of the same cell lines, data show the average (n = 3)±s.d. (*) p-value<0.05 by t-test. (b) Quantification of Ifnb1
expression of ESCs lacking Dgcr8 or Dicer to stimulation with poly(I:C) and G3-YSD. Data show average (n = 3)±s.d., normalized to mock, (*)
Figure 2 continued on next page
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observations, we blocked IFN signalling using the JAK1/2 inhibitor Ruxolitinib before infecting cells
with TMEV. As a result we observed no, or a very mild increase in TMEV viral replication in wild-type
ESCs, but a significant increase in viral replication in miRNA-deficient ESCs (Figure 2C and Fig-
ure 2—figure supplement 2D). ESCs were also stimulated with exogenous IFN-b and confirmed
that mouse ESCs retain the ability to respond to external IFNs, and, importantly, that miRNA defi-
ciency did not alter ISG expression levels, supporting the hypothesis that the miRNA-mediated
silencing of the IFN pathway in ESCs occurs upstream of IFN production (Figure 2D). To verify that
the observed results are solely due to the absence of miRNAs, we rescued the knock-out cell lines
by reintroducing Dgcr8 and Dicer and observed that these reverted to wild-type viral replication and
susceptibility levels (Figure 2E,F and Figure 2—figure supplement 2E). As a control, we confirmed
rescue of miRNA production by Northern blot (Figure 2E,F).
miRNAs suppress MAVS expression in ESCs
To understand where the IFN pathway is silenced in ESCs we blocked the interferon response at
defined points in the pathway and measured viral susceptibility. The inhibitor BX795 blocks TBK1/
IKKe phosphorylation and consequently IRF3 transcriptional activity, whereas BMS345541 is an inhib-
itor of the catalytic subunits of IKK and thus blocks Nf-kB-driven transcription. Both transcription fac-
tors are essential for the expression of Ifnb1 and other pro-inflammatory cytokines and initiation of
an antiviral response (Lawrence, 2009; Schafer et al., 1998). Both inhibitors increased viral suscepti-
bility in wild-type cells lines, however, the effect was far greater in the knock-out cell lines
(Figure 3A,B and Figure 3—figure supplement 1A–C), suggesting that miRNAs regulate the inter-
feron pathway upstream Ifnb1 transcription.
We next aimed to identify the mechanism by which miRNAs silence IFN expression in ESCs, and
analysed the proteomes of Dgcr8-/- and the rescued cell line by mass spectrometry. STRING analyses
of the expression profiles revealed significant differences in a number of pathways, including ribo-
some structure/function, mitochondrial activity and the oxidative phosphorylation pathway, which
were downregulated in the absence of miRNAs (Figure 3C, for complete list see Figure 3—source
data 1). Measurement of Rhodamine 123 uptake in mitochondria, as an indirect measure for oxida-
tive phosphorylation activity (Scaduto and Grotyohann, 1999), confirmed lower oxidative phosphor-
ylation activity in the absence of miRNAs (Dgcr8-/- and Dicer-/-) (Figure 3—figure supplement 1D).
A search for differentially expressed proteins involved in the IFN response did not reveal any signifi-
cant changes except for the Mitochondrial antiviral-signalling protein (MAVS), which in contrast to
many other mitochondria-related proteins, was upregulated in the absence of miRNAs. This protein
has a central role in the RLR-induced (Rig-I-like receptors) IFN pathway, where activated MDA5 and
RIG-I receptors translocate to the mitochondria and bind MAVS to ultimately induce Ifnb1 expres-
sion (Kawai et al., 2005). Western blot and qRT-PCR analysis confirmed that MAVS was the only fac-
tor consistently expressed to higher levels in both miRNA-deficient cell lines, Dgcr8-/- and Dicer-/-
(Figure 3D, lanes 2 and 5, and Figure 3—figure supplement 1E), compared to a panel of other
components of the same innate immune response pathway (Figure 3—figure supplement 1F).
Figure 2 continued
p-value<0.05 by t-test. (c) Quantification of TMEV vRNA upon JAK1/2 inhibition by Ruxolitinib treatment. Data show the average (n = 3)±s.d. (d) qRT-
PCR analyses of ISGs expression after stimulation of wild-type and miRNA-deficient ESCs with IFN-b. Data show average (n = 3)±s.d., normalized to
mock treated cells (e, f) Quantification of TMEV replication after infection in Dgcr8 (e) and Dicer (f) parental (+/+), deficient (-/-) and rescued (resc) cell
lines. Data are normalized to miRNA-deficient cell lines susceptibility. Data show the average (n = 3)±s.d (*) p-value<0.05 by t-test. Northern blots for
three stem-cell specific miRNAs, as control for knock-out and rescue of Dgcr8 and Dicer, are shown at the right of each panel.
DOI: https://doi.org/10.7554/eLife.44171.005
The following figure supplements are available for figure 2:
Figure supplement 1. Viral entry in miRNA-deficient and wild-type ESCs.
DOI: https://doi.org/10.7554/eLife.44171.006
Figure supplement 2. miRNA-deficient ESCs express IFN in response to dsRNA.
DOI: https://doi.org/10.7554/eLife.44171.007
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Figure 3. MAVS is downregulated by miRNAs in ESCs. (a, b) Susceptibility of Dgcr8-/-, Dicer-/- and parental cells to TMEV infection after inhibition of
IRF3 (BX795) (a) and Nf-kB (BMS345541) (b), normalized to mock-treated cells. (c) Heat map of significantly differentially expressed proteins (p<0.05) in
the absence (Dgcr8-/-) or presence (Dgcr8resc) of miRNAs identified by STRING analysis. (d) Western blot analysis of MAVS expression in miRNA-
deficient cells (Dgcr8-/- and Dicer-/-, lanes 2 and 5), wild-type counterparts (Dgcr8+/+ and Dicer+/+, lanes 1 and 4) and respective rescued ESCs lines
(Dgcr8resc and Dicerresc, lanes 3 and 6). MAVS quantification normalized to Tubulin and relative to wild-type levels is shown at the top of the panel.
DOI: https://doi.org/10.7554/eLife.44171.008
The following source data and figure supplement are available for figure 3:
Source data 1. Source data of mass spectrometry results.
DOI: https://doi.org/10.7554/eLife.44171.010
Figure 3 continued on next page
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MAVS acts as a switch for IFN expression
To confirm the involvement of miRNAs on MAVS expression, a dual luciferase assay system was
used where the 3’UTRs of Mavs, Mda5 and Rig-I were fused to a luciferase reporter gene to com-
pare luciferase activity in wild-type and knock-out ESCs. Only the Mavs 3’UTR showed relatively
higher luciferase expression levels in the knock-out lines when compared to the empty plasmid, sug-
gesting that the 3’UTR of Mavs is strongly regulated by miRNAs in ESCs (Figure 4A). For this reason,
a miRNA-resistant form of Mavs, lacking its natural 3’UTR, was overexpressed in wild-type ESCs and
infected with TMEV to test if cells regain viral resistance similar to miRNA deficient
ESCs (Figure 4B). A 15-fold decrease in TCID50 and significant reduction in vRNA levels were found
compared to wild-type ESCs (Figure 4C). MAVS overexpressing cells also regained the ability to
produce Ifnb1 after stimulation with poly(I:C) (Figure 4D). All these experiments show that MAVS is
a crucial target for the absence of the IFN response in ESCs.
miR-673 is crucial to suppress antiviral immunity in ESCs
We next aimed to identify the miRNA(s) responsible for the regulation of MAVS in ESCs and
selected a number of miRNA candidates based on literature, prediction software and public miRNA
expression databases for further investigations. Previous experimental evidence has shown that
human MAVS is regulated by miR-125a, miR-125b and miR-22 (Hsu et al., 2017; Wan et al., 2016).
However, only miR-125a-5p and miR-125b-5p have conserved binding sites in mouse MAVS. Two
additional miRNAs, miR-185–5p and miR-673–5p, were selected based on their DICER and DGCR8-
dependent biosynthesis pathway, their high expression levels in mouse ESCs and number of pre-
dicted binding sites in the Mavs 3’UTR (Tang et al., 2006; Babiarz et al., 2008). We transfected
Dgcr8-/- cells with mimics of these miRNAs and measured Mavs mRNA and protein levels by RT-
qPCR and western blot, respectively. Results showed reductions in MAVS protein and mRNA levels
for all tested miRNAs (Figure 5A and Figure 5—figure supplement 1A). The infection of miRNA-
transfected Dgcr8-/- cells with TMEV resulted in an increase in both susceptibility and viral replication
for miR-125a-5p, miR-125b-5p and miR-673–5p, which correlated with the ability of these miRNAs to
downregulate MAVS protein levels (Figure 5B and Figure 5—figure supplement 1B).
As an alternative approach, Dgcr8+/+ cells were transfected with inhibitors to miRNAs miR-125a-
5p, miR-125b-5p and miR-673–5p. Western blot analysis showed a clear increase in MAVS protein
expression, especially for anti-miR-673–5p (Figure 5C). Because miR-673–5p showed the largest
effect on MAVS protein expression both when depleted and overexpressed, we hypothesize that
miR-673 is a crucial miRNA involved on MAVS regulation.
We further investigated the role of miR-673–5p in ESCs by creating stable knock-out cell lines for
this miRNA by CRISPR/Cas9. Three cell lines were selected based on the genomic deletion and con-
firmed undetectable expression of miR-673–5p (Figure 5—figure supplement 2A,B). The absence
of miR-673–5p was enough to observe an increase in MAVS expression both at the mRNA and pro-
tein levels (Figure 5D and Figure 5—figure supplement 2C). In addition, we measured miR-673
and MAVS expression levels in the mouse fibroblasts cell line, NIH3T3, which is proficient in produc-
ing IFN in response to dsRNA. Mouse fibroblasts had no detectable miR-673–5p, and MAVS protein
expression was comparable to miRNA-deficient ESC (Figure 5D and Figure 5—figure supplement
2B), highlighting the correlation of MAVS expression with the ability of cells to activate Ifnb1 expres-
sion in response to immunogenic RNA.
Next, miR-673-deficient cell lines were tested for TMEV susceptibility, which showed a consistent
decrease in virus replication, similar to that observed in the absence of all miRNAs (Dgcr8-/-), sug-
gesting this miRNA is essential in regulating the innate antiviral response in ESCs (Figure 5E). To
test the relevance of IFNs on the increased antiviral resistance of miR-673-/- cell lines, we compared
their sensitivity to TMEV infections in the presence of the JAK1/2 inhibitor, Ruxolitinib. Whereas inhi-
bition of IFN signalling did not significantly increase the accumulation of viral RNA in wild-type ESCs
(Dgcr8+/+), both miR-673-deficient and Dgcr8-/- ESCs showed a significant increase in viral RNA
Figure 3 continued
Figure supplement 1. miRNAs regulate MAVS and mitochondrial activity.
DOI: https://doi.org/10.7554/eLife.44171.009
Witteveldt et al. eLife 2019;8:e44171. DOI: https://doi.org/10.7554/eLife.44171 8 of 19
Research article Chromosomes and Gene Expression Stem Cells and Regenerative Medicine
upon treatment, confirming the role of miR-673 and IFNs in viral susceptibility (Figure 5F and Fig-
ure 5—figure supplement 3A). As controls, we confirmed that knocking out miR-673–5p expression
did not affect the ability of ESCs to proliferate or induced spontaneous differentiation, which could
cause differences in viral susceptibility (Figure 5—figure supplement 3B–E). Interestingly, during
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Figure 4. ESCs regain Ifnb1 expression after MAVS overexpression. (a) Dual luciferase assay with Mavs, Rig-I and Mda5 3’UTRs in miRNA-deficient cells
lines (Dgcr8-/- and Dicer-/-). Data show the average (n = 3)±s.d normalized to Renilla and relative to the parental lines, (*) p-value<0.05 by t-test (b)
Western blot of cell line overexpressing MAVS lacking the 3’UTR in Dgcr8+/+ cells (lane 3). MAVS quantification normalized to Tubulin and relative to
wild-type is shown at the top (c) Susceptibility (TCID50/ml) of same cells lines as in (b) to TMEV infection (left panel) and quantification of viral RNA after
TMEV infections in the same cell lines (right panel). Data show the average (n = 5)±s.d. (*) p-value<0.05 by t-test (d) Ifnb mRNA expression after poly(I:
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Figure 5. MiR-673–5p regulates MAVS. (a) Transfection of miRNA mimics miR-125a-5p, miR-125b-5p, miR-185–5p and miR-673–5p in Dgcr8-/- cells
followed by MAVS western blot. MAVS quantification normalized to Tubulin and relative to wild-type is shown at the top (b) Quantification of TMEV
replication by qRT-PCR in the same cell lines as in (a) (n = 3) (c) Western blot analysis of MAVS expression in Dgcr8+/+ cells transfected with antagomirs
against miR-125a-5p, miR-125b-5p and miR-673–5p. MAVS quantification normalized to Tubulin and relative to wild-type is shown at the top (d)
Figure 5 continued on next page
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ESC differentiation with retinoic acid, expression of miR-673–5p became silenced, confirming previ-
ous results obtained with alternative differentiation protocols (Knelangen et al., 2011; Zhao et al.,
2014; Hadjimichael et al., 2016; Yang et al., 2016), and suggesting that the expression levels of
this miRNA negatively correlate with the ability of cells to activate the IFN response (Figure 5G).
Collectively, these data show that the IFN response in mouse ESCs is silenced by the post-tran-
scriptional control of Mavs expression by miR-673–5p.
Discussion
Several studies suggest that the pluripotent state of a cell is incompatible with an active IFN
response (Guo et al., 2015). Both mouse and human stem cells fail to synthesize IFNs in response to
dsRNA (Wang et al., 2013; Chen et al., 2010), implying that this characteristic is acquired during
differentiation (D’Angelo et al., 2016). Embryonic carcinoma cells, which are still pluripotent, also
fail to produce IFNs in response to viral RNA mimics (Burke et al., 1978). In agreement, reprogram-
ming of somatic cells to iPSCs (induced pluripotent stem cells) leads to a loss of IFN response, sug-
gesting the presence of regulatory mechanisms able to switch this antiviral pathway on or off
between the differentiated and pluripotent states (Chen et al., 2012). Another feature of pluripotent
cells is their attenuated response to exogenous type I IFNs. Mammalian pluripotent stem cells, iPSCs
and embryonic carcinoma cells exhibit an attenuated production of ISGs upon type I IFN stimulation
(Hong and Carmichael, 2013; Irudayam et al., 2015; Wang et al., 2014; Burke et al., 1978). Why
these activities are supressed is still not understood, but it has been hypothesized that type I IFN
stimulation could impair their self-renewal capacity, since these compounds are well-known antiproli-
ferative agents and inducers of cell death (Bekisz et al., 2010). Indeed, type I IFNs are capable of
inhibiting tumour cell division in vitro and are currently employed as an adjuvant to treat several
types of cancers, acting as stimulants of the innate immune cellular response (Bracci et al., 2017).
Mouse ESCs express low levels of the RNA sensors TLR3, MDA5 and RIG-I, which could explain
their inability to respond to dsRNA although no functional studies support this model so far
(Wang et al., 2013). Our data shows an alternative scenario in which MAVS is the key factor for con-
trolling the IFN response. The overexpression of a miRNA-resistant form of MAVS in wild-type ESCs
is enough to enable dsRNA-mediated IFN activation, suggesting that dsRNA sensing is not a limiting
step in the IFN pathway in ESCs. Regulation of MAVS alone proves to be an efficient mechanism to
block dsRNA induced IFN expression compared to suppressing individual dsRNA sensors.
The observation that miRNAs only suppress RNA-mediated IFN activation, but not the DNA-
mediated pathway, leads us to speculate about the reasons for silencing this specific response dur-
ing pluripotency. Embryonic stem cells, and also earlier stages of embryonic development are char-
acterized by high expression levels of specific retrotransposons (non-LTR) and endogenous
retroviruses (LTR), which are a hallmark of their pluripotent state. This is in contrast to most somatic
cell types that silence their expression (Yin et al., 2018). These repetitive elements produce cyto-
plasmic RNA molecules as an intermediate for mobilisation, which can be accidentally recognised as
immunogenic or non-self RNAs, as it has been previously shown for the human non-LTR
Figure 5 continued
Western blot analysis of MAVS expression in miR-673-/- cell lines. MAVS quantification normalized to Tubulin and relative to wild-type is shown at the
top (e) Quantification of TMEV vRNA in miR-673 CRISPR knock-out cell lines in a Dgcr8+/+ background. Data show the average (n = 3)±s.d (*)
p-value<0.05 by t-test. (f) Quantification of TMEV vRNA shown as fold-change compared to mock upon JAK1/2 inhibition by Ruxolitinib treatment. Data
show the average (n = 3)±s.d (g) qRT-PCR quantification of mmu-miR-673–5p expression after retinoic acid (RA) differentiation of ESC. Data
show the average (n = 2)±s.e.m, normalized to U6 snRNA, (*) p-val <0.05 by t-test.
DOI: https://doi.org/10.7554/eLife.44171.012
The following figure supplements are available for figure 5:
Figure supplement 1. Characterization of MAVS expression in ESCs and regulation by miRNAs.
DOI: https://doi.org/10.7554/eLife.44171.013
Figure supplement 2. Characterization of miR-673-/- mouse embryonic stem cells.
DOI: https://doi.org/10.7554/eLife.44171.014
Figure supplement 3. Characterization of miR-673 -/- mouse ESCs.
DOI: https://doi.org/10.7554/eLife.44171.015
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retroelement Alu in the context of Aicardi-Goutires syndrome or for endogenous retroviruses
(Ahmad et al., 2018; Chiappinelli et al., 2015; Roulois et al., 2015). Therefore, silencing the RNA-
mediated IFN response during pluripotency would act as a protective mechanism for aberrant IFN
activation by transposon-derived transcripts.
Cells that are incapable of activating the RNA-mediated IFN response have developed alternative
antiviral defence pathways. The endonuclease DICER can act as an antiviral factor in mouse ESCs by
generating antiviral siRNAs (Maillard et al., 2013). Detection of antiviral DICER activity is facilitated
in the absence of a competent IFN response, such as in the case of pluripotent cells, but also in
somatic cells where the type I IFN response has been genetically impaired (Maillard et al., 2016).
These findings are supported by the observation that in IFN-competent cells, the RNA sensor LGP2
acts as an inhibitor of DICER cleavage activity on dsRNA (van der Veen et al., 2018). However,
DICER activity has also been reported in other cell lines, independently of their IFN-proficiency
capacity (Li et al., 2016). Interestingly, when we disrupt Dicer in ESCs, which inherently lack an IFN
response and would theoretically render these cells highly sensitive to viral infections, they become
more resistant by acquiring an active IFN response. All these results support the presence of exten-
sive cross-talk between the different antiviral strategies, and suggests that cells have developed
mechanisms to compensate for the loss of a specific antiviral pathway.
Our model shows that MAVS and miR-673 levels are the key factors regulating the IFN response
to dsRNAs during pluripotency. Accordingly, overexpressing MAVS or knocking-out this single
miRNA in ESCs is enough to enhance their antiviral response. Interestingly, this miRNA is only con-
served in rodents, despite human ESCs also suppressing type I IFNs expression (Hong and Carmi-
chael, 2013). This suggests that either other miRNAs regulate MAVS expression in human ESCs, or
alternative mechanisms operate to silence IFN. Interestingly, human and mouse ESCs have been sug-
gested to constitutively express a subset of ISGs to protect them from viruses (Wu et al., 2018). Our
proteomics data suggest that, from all the ISGs detected, miRNAs did not significantly affect pro-
duction of these antiviral factors, such as IFITM1, IFTIM2, IFITM3 amongst others. We have shown
that engineering ESCs to acquire a functional IFN response significantly increases their antiviral
immunity, highlighting the powerful antiviral effects of IFNs even during pluripotency.
Previous findings also support a general role for DICER and miRNAs acting as negative regulators
of the IFN response in human and mouse models outside pluripotency (Papadopoulou et al., 2012;
Witteveldt et al., 2018). In agreement, an indirect approach to deplete cellular miRNAs, by overex-
pressing the viral protein VP55 from Vaccinia virus, showed that miRNAs are also relevant to control
the expression of pro-inflammatory cytokines during viral chronic infections, but not in the acute
antiviral response (Aguado et al., 2015). However, the concept of miRNAs acting as direct antiviral
factors is still controversial. It is relevant to mention that some of the results leading to this conclu-
sion have been primarily generated in DICER1-/- HEK293T human cell line (Bogerd et al., 2014;
Tsai et al., 2018), which has an attenuated IFN response due to low PRRs expression (Rice et al.,
2014; Witteveldt et al., 2018).
We have shown that overexpression of MAVS or silencing specific miRNAs in a transient or stable
manner improves the antiviral response of ESCs. These findings are the basis to further study the
conservation of the miRNA-mediated regulation of the IFN response in somatic cells and in the con-
text of human pluripotency. All these investigations will provide a deeper understanding and tool
set on how to enhance the innate immunity of ESCs and their differentiated progeny, an especially
relevant aspect in clinical applications.
Materials and methods
Cells and viruses
Dgcr8 knockout (Dgcr8-/-) mouse ESCs were purchased from Novus Biologicals (NBA1-19349) and
the parental strain, v6.5 (Dgcr8+/+, also named in the text ESC1) from ThermoFisher (MES1402).
Dicer flox/flox (Dicer+/+, also named ESC2) and Dicer knockout (Dicer-/-) mouse ESCs were provided
by R. Blelloch lab (University of California, San Francisco). All mESC cells were cultured in Dulbecco’s
modified Eagle Medium (DMEM, ThermoFisher) supplemented with 15% heat-inactivated foetal calf
serum (ThermoFisher), 100 U/ml penicillin, 100 mg/ml streptomycin (ThermoFisher), 1X Minimal
essential amino acids (ThermoFisher), 2 mM L-glutamine, 103 U/ml of LIF (Stemcell Technologies)
Witteveldt et al. eLife 2019;8:e44171. DOI: https://doi.org/10.7554/eLife.44171 12 of 19
Research article Chromosomes and Gene Expression Stem Cells and Regenerative Medicine
and 50 mM 2-mercaptoethanol (ThermoFisher). Cells were grown on plates coated with 0.1% Gela-
tine (Embryomax, Millipore), detached using 0.05% Trypsin (ThermoFisher) and incubated at 5%
CO2 at 37˚C. MDCK, BHK-21, BV-2 and RAW264.7 cells were cultured in Dulbecco’s modified Eagle
Medium (DMEM, ThermoFisher) supplemented with 10% heat-inactivated foetal calf serum (Thermo-
Fisher), 100 U/ml penicillin, 100 mg/ml streptomycin (ThermoFisher), 2 mM L-glutamine and incu-
bated at 5% CO2 at 37˚C. NIH3T3 cell line was provided by A. Buck lab, and grown in DMEM
supplemented with 10% FCS. To determine cell proliferation kinetics, cells were seeded in 6-well
plates at a density of 2*105 cells/well. Cell numbers were determined in triplicates after 12, 24, 36
and 48 hr using a CASY cell counter.
Stocks of TMEV strain GDVII were grown on BHK-21 cells and frozen in aliquots at  80˚C. Stocks
of Influenza A virus strain PR8 (kindly provided by P. Digard, University of Edinburgh) were grown on
MDCK cells in the absence of serum and in the presence of 2 mg/ml TPCK-treated trypsin and frozen
in aliquots at  80˚C. For TMEV infections, cells were infected for 1 hr with the required dilution, fol-
lowed by replacement with fresh medium and incubation for the desired time. For the 50% Tissue
Culture Infective dose (TCID50) assays, seven serial dilutions of TMEV were prepared and at least six
wells (in 96-well format) per dilution were infected and incubated for at least 24 hr before counting
infected wells. TCID50 values were calculated using the Spearman and Ka¨rber algorithm. Influenza A
virus infections were performed by infecting cells in the absence of serum for 45 min with the addi-
tion of 2 mg/ml TPCK-treated trypsin. After replacement of the inoculum with fresh serum containing
medium the cells were incubated for the desired period.
Differentiation of mESCs
To differentiate mESCs, they were first cultured as hanging droplets to induce embryoid body for-
mation. For this, a single-cell suspension of 5  105 cells/ml was prepared in medium without LIF
and 20 ml drops are pipetted on the inside of the lid of a 10 cm petri dish and hung upside-down.
The petri-dish was filled with PBS to prevent drying of the hanging drops and incubated at 37˚C, 5%
CO2 for 48 hr. The embryoid bodies were consequently washed from the lids and transferred to
petri dishes to further differentiate, all in the absence of LIF. After another incubation time of 48 hr,
medium was removed and replaced with fresh medium containing 250 nM of retinoic acid (Sigma-
Aldrich) and incubated for 7 days while replacing the medium every 48 hr. After this incubation time,
the embryoid bodies were collected and plated on normal gelatine-coated cell culture plates which
allowed the embryoid bodies to adhere to the plastic and the cells to migrate from the embryoid
bodies. Again, the medium was refreshed every 48 hr for the cells to further differentiate.
Northern blot for miRNAs
Total RNA (15 mg) was loaded on a 10% TBE-UREA gel. After electrophoresis, gel was stained with
SYBR gold for visualization of equal loading. Gel was transferred onto a positively charged Nylon
membrane for 1 hr at 250 mA. After UV-crosslinking, the membrane was pre-hybridized for 4 hr at
40˚C in 1xSSC, 1%SDS (w/v) and 100 mg/ml single-stranded DNA (Sigma). Radioactively labelled
probes corresponding to the highly expressed ESCs miRNAs miR-130–3 p, miR-293–3 p, and miR-
294–3 p were synthesized using the mirVana miRNA Probe Construction Kit (Ambion) and hybridized
overnight in 1xSSC, 1%SDS (w/v) and 100 mg/ml ssDNA. After hybridization, membranes were
washed four times at 40˚C in 0.2xSSC and 0.2%SDS (w/v) for 30 min each. Blots were analysed using
a PhosphorImager (Molecular Dynamics) and ImageQuant TL software for quantification. Oligonu-
cleotides used are listed in Supplementary file 1.
Transfections of poly(I:C), DNA, miRNA mimics and Antagomirs
To activate the IFN response, cells were transfected with either the dsRNA analogue poly(I:C) (Inviv-
ogen) or the Y-shaped-DNA cGAS agonist (G3-YSD, Invivogen) using Lipofectamine 2000 (Thermo-
Fisher). Transfections were performed in 24-well format, with cells approximately 80% confluent,
using different concentrations of poly(I:C), from 0,5 to 2,5 mg per well (as indicated in the figures) or
0.5 mg of G3-YSD. Cells were incubated for approximately 16 hr for poly(I:C)- and 8 hr for DNA-
transfections before harvest and further processing. IFN-b expression was measured using a quanti-
tative ELISA kit (Mouse IFN-b, Quantikine, R and D systems) according to manufacturer’s instruc-
tions. Cells were transfected with 2.5 mg/ml poly(I:C), incubated for 16 hr after which supernatant
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was collected and assayed for IFN-b. To activate ESCs with exogenous IFN-b (R and D systems), cells
were incubated with 10.000 U/ml of IFN-b for 4 hr, followed by RNA extraction and quantitative RT-
PCR.
For the miRNA mimics (miScript, Qiagen) a final concentration of 1 mM was transfected into cells
using Dharmafect (Dharmacon), incubated for the desired period and further processed. The same
procedure was followed for the antagomirs (Dharmacon), but at a concentration of 100 nM. All
experiments were performed in 24-well format, with cells at approximately 80% confluency.
Quantitative RT-PCR
Total RNA from cells was isolated using Tri reagent (Sigma-Aldrich) according to the manufacturer’s
instructions. 0.5–1 mg RNA was subsequently reverse transcribed using M-MLV (Promega) and ran-
dom hexamers, and used for quantitative PCR in a StepOnePlus real-time PCR machine (Thermo-
Fisher) using GoTaq master mix (Promega). Data was analysed using the StepOne software package.
Oligonucleotides used are listed in Supplementary file 1.
Cell lysis and western blots
Cells used for Western blot analysis were lysed in RIPA buffer (50 mM TRIS-HCl, pH 7.4, 1% triton
X-100, 0.5% Na-deoxycholate, 0.1% SDS, 150 mM NaCl, protease inhibitor cocktail (Roche), 5 mM
NaF, 0.2 mM Sodium orthovanadate). Lysates were spun and protein concentrations measured using
a BCA protein assay kit (BioVision). After adjusting protein concentrations, lysates were mixed with
reducing agent (Novex, ThermoFisher) and LDS sample buffer (Novex, ThermoFisher) and boiled at
70˚C for 10 min before loading on pre-made gels (NuPAGE, ThermoFisher). Proteins were trans-
ferred to nitrocellulose membrane using semi-dry transfer (iBlot2, ThermoFisher). Membranes were
blocked for 1 hr at room temperature in PBS-T (0.1% Tween-20) and 5% milk powder before over-
night incubation at 4˚C with primary antibody. Antibodies used were: Anti-rabbit HRP (Cell Signaling
Technology), Anti-mouse HRP (Bio-Rad), MAVS (E-6, Santa Cruz Biotechnology), PKR (ab45427,
Abcam), MDA5 (D74E4, Cell Signaling Technology), RIG-I (D12G6, Cell Signaling Technology), phos-
pho-IRF-3 (D601M, Cell Signaling Technology) and a-tubulin (CP06, Merck). Proteins bands were
visualised using ECL (Pierce) on a Bio-Rad ChemiDoc imaging system. Protein bands were quantified
using ImageJ (v1.51p) software and expression levels calculated normalized to a-tubulin.
Luciferase assay
The 3’UTRs from Mda5, Rig-I and Mavs were amplified from genomic DNA based on the annotation
from UTRdb (utrdb.ba.itb.cnr.it) using primers containing restriction sites. The fragments were
cloned in the psiCHECK-2 vector (Promega) at the 3’ end of the hRluc gene. Cells in 24-well format
were transfected with 250 ng plasmid using Lipofectamine 2000 and incubated for 24 hr. Cells were
subsequently lysed and assayed using the Dual-Glo Luciferase assay system (Promega). Lumines-
cence was measured in a Varioskan flash (ThermoFisher) platereader.
Proteomics
For the total proteome comparison, 6 replicates of the Dgcr8-/- and Dgcr8resc cell lines were pre-
pared by lysing cells in Lysis buffer (50 mM TRIS-HCl, pH 7.4, 1% triton X-100, 0.5% Na-deoxycho-
late, 0.1% SDS, 150 mM NaCl, protease inhibitor cocktail (Roche), 5 mM NaF and 0.2 mM Sodium
orthovanadate) at 4˚C. Samples were subsequently sonicated 4  10 s, at 2m amplitude, reduced by
boiling with 10 mM DTT and centrifuged. The samples were further processed by Filter-aided sam-
ple preparation (FASP) by mixing each sample with 200 ml UA (8M Urea, 0.1 M Tris/HCl pH 8.5) in a
Vivacon 500 filter column (30 kDa cut off, Sartorius VN01H22), centrifuged at 14.000 x g and washed
twice with 200 ml UA. To alkylate the sample, 100 ml 50 mM iodoacetamide in UA was applied to the
columns and incubated in the dark for 30 min, spun, followed by two washes with UA and another
two washes with 50 mM ammonium bicarbonate. The samples were trypsinized on the column by
the addition of 4 mg trypsin (ThermoFisher) in 40 ml 50 mM ammonium bicarbonate to the filter. Sam-
ples were incubated overnight in a wet chamber at 37˚C and acidified by the addition of 5 ml 10% tri-
fluoroacetic acid (TFA). The pH was checked by spotting onto pH paper, and peptide concentration
estimated using a NanoDrop. C18 Stage tips were activated using 20 ml of methanol, equilibrated
with 100 ml 0.1% TFA) and loaded with 10 mg peptide solution. After washing with 100 uL 0.1% TFA,
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the bound peptides were eluted into a Protein LoBind 1.5 mL tube (Eppendorf) with 20 ml 80% ace-
tonitrile, 0.1% TFA and concentrated to less than 4 ml in a vacuum concentrator. The final volume
was adjusted to 6 ml with 0.1% TFA.
Five mg of peptides were injected onto a C18 packed emitter and eluted over a gradient of 2–
80% ACN in 120 min, with 0.1% TFA throughout on a Dionex RSLnano. Eluting peptides were ion-
ised at +2 kV before data-dependent analysis on a Thermo Q-Exactive Plus. MS1 was acquired with
mz range 300–1650 and resolution 70,000, and top 12 ions were selected for fragmentation with
normalised collision energy of 26, and an exclusion window of 30 s. MS2 were collected with resolu-
tion 17,500. The AGC targets for MS1 and MS2 were 3e6 and 5e4 respectively, and all spectra were
acquired with one microscan and without lockmass. Finally, the data were analysed using MaxQuant
(v 1.5.7.4) in conjunction with uniprot fasta database 2017_02, with match between runs (MS/MS not
required), LFQ with one peptide required. Average expression levels were calculated for each pro-
tein and significant differences identified using a two tailed t-test assuming equal variance (homosce-
dasticity) with a p-value lower than 0.05.
Stable cell lines overexpressing DGCR8, Dicer and MAVS
Plasmids containing the sequence of mouse DICER (pCAGEN-SBP-DICER1, Addgene), MAVS (GE-
healthcare, MMM1013-202764911) and DGCR8 (Macias et al., 2012) were used to amplify the open
reading frame using specific primers containing restriction sites (Supplementary file 1). The ampli-
fied and digested fragments were ligated in pLenti-GIII-EF1a for MAVS and pEF1a-IRES-dsRED-
Express2 for DGCR8 and DICER. Verified plasmids containing the genes of interest were transfected
in mESCs using Lipofectamine 2000 and selected with the appropriate antibiotic. After several weeks
of selection, colonies were isolated, expanded and tested for expression by qRT-PCR and Western
blot.
Mitochondrial activity
The mitochondria specific dye Rhodamine 123 (Sigma-Aldrich) was used to measure mitochondrial
activity. Suspended cells were incubated with Rhodamine 123 at 37˚C and samples were taken at
various intervals, washed three times with PBS at 4˚C and the fluorescence measured in a VarioSkan
flash (ThermoFisher) plate reader (excitation 508, emission 535).
Inhibitors
Cells were pre-incubated with the inhibitors BX795, which blocks the phosphorylation of the kinases
TBK1 and IKKe, and consequently IRF3 activation and IFN-b production (10 mM, Synkinase) and the
inhibitor BMS345541, which targets IKba, IKKa and IKKb and consequently NF-kb signalling (10 mM,
Cayman Chemical) for 45 min before infection with TMEV. 24 hr post-infection in the presence of the
inhibitor, infected wells were scored and the TCID50 calculated. For Ruxolitinib (Cell Guidance Sys-
tems), cells were pre-incubated for 45 min with 50 mM Ruxotlitinib, infected with TMEV and incu-
bated for 16 hr followed by extensive washing with PBS, RNA extraction and analysis by quantitative
RT-PCR.
CRISPR/Cas 9 targeting of mmu-miR-673
To create a cell line lacking mmu-mmiR-673–5p, the Alt-R CRISPR-Cas9 System (IDT) was used. Two
different crRNAs were designed to target sequences within the pri-miRNA sequence hairpin to
induce structural changes disrupting processing by the Microprocessor and DICER. Cas9 protein and
tracrRNAs were transfected with the Neon Transfection System followed by cell sorting to create sin-
gle cell clones. Genomic DNA was purified and screened by PCR followed by restriction site disrup-
tion analyses for the pri-miRNA sequence. Genomic DNA of the pri-miRNA sequence of candidates
was amplified using primers in Supplementary file 1, and cloned into pGEMt-easy vector for
sequencing.
miRNA qRT-PCR
Total RNA (100 ng) was used to quantify mmu-mmiR-673–5p levels. RNA was first converted to
cDNA using miRCURY LNA RT kit (Qiagen). cDNA was diluted 1/25 for RT-qPCR using miRCURY
LNA SYBR Green kit and amplified using mmu-mmiR-673–5p specific primers (Qiagen) and U6 as a
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loading control. Quantitative PCR was carried out on a Roche LC480 light cycler and analysed using
the second derivative method.
Data availability
All processed Mass spectrometry data is provided as Figure 3—source data 1, including LFQ inten-
sity values for each protein detected in each of the samples. All raw data are available from corre-
sponding author upon request.
Acknowledgements
We thank our colleagues at the Institute of Immunology and Infection Research for advice and dis-
cussions. We thank JF Caceres, H Marks, R Zamoyska and Y Crow for critical reading of the manu-
script, and R Blelloch, P Digard, E Gaunt and R Zamoyska labs for reagents. We thank Jimi Wills
from the IGMM Mass spectrometry facility for analysis of protein samples. This work is supported by
the Wellcome Trust (107665/Z/15/Z), LK is supported by a MRC-DTP in Precision Medicine
Fellowship.
Additional information
Funding
Funder Grant reference number Author
Wellcome 107665/Z/15/Z Sara Macias
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
Jeroen Witteveldt, Conceptualization, Data curation, Formal analysis, Supervision, Validation, Investi-
gation, Methodology, Writing—original draft, Writing—review and editing; Lisanne I Knol, Formal
analysis, Investigation, Writing—review and editing; Sara Macias, Conceptualization, Supervision,
Funding acquisition, Investigation, Methodology, Writing—original draft, Writing—review and
editing
Author ORCIDs
Jeroen Witteveldt http://orcid.org/0000-0001-8247-7010
Lisanne I Knol http://orcid.org/0000-0002-8975-0398
Sara Macias http://orcid.org/0000-0002-0643-3494
Decision letter and Author response
Decision letter https://doi.org/10.7554/eLife.44171.022
Author response https://doi.org/10.7554/eLife.44171.023
Additional files
Supplementary files
. Supplementary file 1. Sequences of the oligonucleotides used in this study.
DOI: https://doi.org/10.7554/eLife.44171.016
. Transparent reporting form
DOI: https://doi.org/10.7554/eLife.44171.017
Data availability
All processed Mass spectrometry data is provided as Figure 3—source data 1, including LFQ inten-
sity values for each protein detected in each of the samples. All raw data are available from corre-
sponding author upon request.
Witteveldt et al. eLife 2019;8:e44171. DOI: https://doi.org/10.7554/eLife.44171 16 of 19
Research article Chromosomes and Gene Expression Stem Cells and Regenerative Medicine
References
Aguado LC, Schmid S, Sachs D, Shim JV, Lim JK, tenOever BR. 2015. microRNA function is limited to cytokine
control in the acute response to virus infection. Cell Host & Microbe 18:714–722. DOI: https://doi.org/10.1016/
j.chom.2015.11.003, PMID: 26651947
Ahmad S, Mu X, Yang F, Greenwald E, Park JW, Jacob E, Zhang CZ, Hur S. 2018. Breaching Self-Tolerance to alu
duplex RNA underlies MDA5-Mediated inflammation. Cell 172:797–810. DOI: https://doi.org/10.1016/j.cell.
2017.12.016, PMID: 29395326
Babiarz JE, Ruby JG, Wang Y, Bartel DP, Blelloch R. 2008. Mouse ES cells express endogenous shRNAs, siRNAs,
and other Microprocessor-independent, Dicer-dependent small RNAs. Genes & Development 22:2773–2785.
DOI: https://doi.org/10.1101/gad.1705308, PMID: 18923076
Bekisz J, Baron S, Balinsky C, Morrow A, Zoon KC. 2010. Antiproliferative properties of type I and type II
interferon. Pharmaceuticals 3:994–1015. DOI: https://doi.org/10.3390/ph3040994, PMID: 20664817
Bernstein E, Caudy AA, Hammond SM, Hannon GJ. 2001. Role for a bidentate ribonuclease in the initiation step
of RNA interference. Nature 409:363–366. DOI: https://doi.org/10.1038/35053110, PMID: 11201747
Bogerd HP, Skalsky RL, Kennedy EM, Furuse Y, Whisnant AW, Flores O, Schultz KL, Putnam N, Barrows NJ,
Sherry B, Scholle F, Garcia-Blanco MA, Griffin DE, Cullen BR. 2014. Replication of many human viruses is
refractory to inhibition by endogenous cellular microRNAs. Journal of Virology 88:8065–8076. DOI: https://doi.
org/10.1128/JVI.00985-14, PMID: 24807715
Borden EC, Hogan TF, Voelkel JG. 1982. Comparative antiproliferative activity in vitro of natural interferons
alpha and beta for diploid and transformed human cells. Cancer Research 42:4948–4953. PMID: 7139598
Bracci L, Sistigu A, Proietti E, Moschella F. 2017. The added value of type I interferons to cytotoxic treatments of
cancer. Cytokine & Growth Factor Reviews 36:89–97. DOI: https://doi.org/10.1016/j.cytogfr.2017.06.008,
PMID: 28693974
Burke DC, Graham CF, Lehman JM. 1978. Appearance of interferon inducibility and sensitivity during
differentiation of murine teratocarcinoma cells in vitro. Cell 13:243–248. DOI: https://doi.org/10.1016/0092-
8674(78)90193-9, PMID: 627035
Chan YK, Gack MU. 2016. Viral evasion of intracellular DNA and RNA sensing. Nature Reviews Microbiology 14:
360–373. DOI: https://doi.org/10.1038/nrmicro.2016.45, PMID: 27174148
Chen LL, Yang L, Carmichael GG. 2010. Molecular basis for an attenuated cytoplasmic dsRNA response in human
embryonic stem cells. Cell Cycle 9:3552–3564. DOI: https://doi.org/10.4161/cc.9.17.12792, PMID: 20814227
Chen GY, Hwang SM, Su HJ, Kuo CY, Luo WY, Lo KW, Huang CC, Chen CL, Yu SH, Hu YC. 2012. Defective
antiviral responses of induced pluripotent stem cells to baculoviral vector transduction. Journal of Virology 86:
8041–8049. DOI: https://doi.org/10.1128/JVI.00808-12, PMID: 22623765
Cheng WY, He XB, Jia HJ, Chen GH, Jin QW, Long ZL, Jing ZZ. 2018. The cGas-Sting signaling pathway is
required for the innate immune response against ectromelia virus. Frontiers in Immunology 9:1297.
DOI: https://doi.org/10.3389/fimmu.2018.01297, PMID: 29963044
Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A,
Makarov V, Budhu S, Buhu S, Slamon DJ, Wolchok JD, Pardoll DM, Beckmann MW, Zahnow CA, Merghoub T,
Mergoub T, et al. 2015. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA
including endogenous retroviruses. Cell 162:974–986. DOI: https://doi.org/10.1016/j.cell.2015.07.011,
PMID: 26317466
D’Angelo W, Acharya D, Wang R, Wang J, Gurung C, Chen B, Bai F, Guo YL. 2016. Development of antiviral
innate immunity during in vitro differentiation of mouse embryonic stem cells. Stem Cells and Development 25:
648–659. DOI: https://doi.org/10.1089/scd.2015.0377, PMID: 26906411
Delorme-Axford E, Sadovsky Y, Coyne CB. 2014. The placenta as a barrier to viral infections. Annual Review of
Virology 1:133–146. DOI: https://doi.org/10.1146/annurev-virology-031413-085524, PMID: 26958718
Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. 2004. The
microprocessor complex mediates the genesis of microRNAs. Nature 432:235–240. DOI: https://doi.org/10.
1038/nature03120, PMID: 15531877
Greve TS, Judson RL, Blelloch R. 2013. microRNA control of mouse and human pluripotent stem cell behavior.
Annual Review of Cell and Developmental Biology 29:213–239. DOI: https://doi.org/10.1146/annurev-cellbio-
101512-122343, PMID: 23875649
Grow EJ, Flynn RA, Chavez SL, Bayless NL, Wossidlo M, Wesche DJ, Martin L, Ware CB, Blish CA, Chang HY,
Pera RA, Wysocka J. 2015. Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent
cells. Nature 522:221–225. DOI: https://doi.org/10.1038/nature14308, PMID: 25896322
Guo Y-L, Carmichael GG, Wang R, Hong X, Acharya D, Huang F, Bai F. 2015. Attenuated innate immunity in
embryonic stem cells and its implications in developmental biology and regenerative medicine. Stem Cells 33:
3165–3173. DOI: https://doi.org/10.1002/stem.2079
Hadjimichael C, Nikolaou C, Papamatheakis J, Kretsovali A. 2016. MicroRNAs for Fine-Tuning of mouse
embryonic stem cell fate decision through regulation of TGF-b signaling. Stem Cell Reports 6:292–301.
DOI: https://doi.org/10.1016/j.stemcr.2016.01.004, PMID: 26876669
Hertzog PJ, Hwang SY, Kola I. 1994. Role of interferons in the regulation of cell proliferation, differentiation, and
development. Molecular Reproduction and Development 39:226–232. DOI: https://doi.org/10.1002/mrd.
1080390216, PMID: 7530016
Witteveldt et al. eLife 2019;8:e44171. DOI: https://doi.org/10.7554/eLife.44171 17 of 19
Research article Chromosomes and Gene Expression Stem Cells and Regenerative Medicine
Herzner AM, Hagmann CA, Goldeck M, Wolter S, Ku¨bler K, Wittmann S, Gramberg T, Andreeva L, Hopfner KP,
Mertens C, Zillinger T, Jin T, Xiao TS, Bartok E, Coch C, Ackermann D, Hornung V, Ludwig J, Barchet W,
Hartmann G, et al. 2015. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as
found in primary HIV-1 cDNA. Nature Immunology 16:1025–1033. DOI: https://doi.org/10.1038/ni.3267,
PMID: 26343537
Hong X-X, Carmichael GG. 2013. Innate immunity in pluripotent human cells. Journal of Biological Chemistry
288:16196–16205. DOI: https://doi.org/10.1074/jbc.M112.435461
Hsu AC, Dua K, Starkey MR, Haw TJ, Nair PM, Nichol K, Zammit N, Grey ST, Baines KJ, Foster PS, Hansbro PM,
Wark PA. 2017. MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral
response in COPD. JCI Insight 2:e90443. DOI: https://doi.org/10.1172/jci.insight.90443, PMID: 28405612
Irudayam JI, Contreras D, Spurka L, Subramanian A, Allen J, Ren S, Kanagavel V, Nguyen Q, Ramaiah A,
Ramamoorthy K, French SW, Klein AS, Funari V, Arumugaswami V. 2015. Characterization of type I interferon
pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection. Stem
Cell Research 15:354–364. DOI: https://doi.org/10.1016/j.scr.2015.08.003, PMID: 26313525
Ivashkiv LB, Donlin LT. 2015. Regulation of type I interferon responses. Nature Reviews Immunology 14:36–49.
DOI: https://doi.org/10.1038/nri3581
Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T, Livingston DM, Rajewsky K. 2005.
Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes &
Development 19:489–501. DOI: https://doi.org/10.1101/gad.1248505, PMID: 15713842
Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor
triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunology 6:981–988. DOI: https://
doi.org/10.1038/ni1243, PMID: 16127453
Knelangen JM, van der Hoek MB, Kong WC, Owens JA, Fischer B, Santos AN. 2011. MicroRNA expression
profile during adipogenic differentiation in mouse embryonic stem cells. Physiological Genomics 43:611–620.
DOI: https://doi.org/10.1152/physiolgenomics.00116.2010, PMID: 21245416
Lawrence T. 2009. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in
Biology 1:a001651. DOI: https://doi.org/10.1101/cshperspect.a001651, PMID: 20457564
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Ra˚dmark O, Kim S, Kim VN. 2003. The nuclear
RNase III drosha initiates microRNA processing. Nature 425:415–419. DOI: https://doi.org/10.1038/
nature01957, PMID: 14508493
Li Y, Basavappa M, Lu J, Dong S, Cronkite DA, Prior JT, Reinecker HC, Hertzog P, Han Y, Li WX, Cheloufi S,
Karginov FV, Ding SW, Jeffrey KL. 2016. Induction and suppression of antiviral RNA interference by influenza A
virus in mammalian cells. Nature Microbiology 2:16250. DOI: https://doi.org/10.1038/nmicrobiol.2016.250,
PMID: 27918527
Macfarlan TS, Gifford WD, Driscoll S, Lettieri K, Rowe HM, Bonanomi D, Firth A, Singer O, Trono D, Pfaff SL.
2012. Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature 487:57–63.
DOI: https://doi.org/10.1038/nature11244, PMID: 22722858
Macia A, Blanco-Jimenez E, Garcı´a-Pe´rez JL. 2015. Retrotransposons in pluripotent cells: impact and new roles in
cellular plasticity. Biochimica Et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1849:417–426.
DOI: https://doi.org/10.1016/j.bbagrm.2014.07.007
Macias S, Plass M, Stajuda A, Michlewski G, Eyras E, Ca´ceres JF. 2012. DGCR8 HITS-CLIP reveals novel functions
for the microprocessor. Nature Structural & Molecular Biology 19:760–766. DOI: https://doi.org/10.1038/nsmb.
2344, PMID: 22796965
Maillard PV, Ciaudo C, Marchais A, Li Y, Jay F, Ding SW, Voinnet O. 2013. Antiviral RNA interference in
mammalian cells. Science 342:235–238. DOI: https://doi.org/10.1126/science.1241930, PMID: 24115438
Maillard PV, Van der Veen AG, Deddouche-Grass S, Rogers NC, Merits A, Reis e Sousa C. 2016. Inactivation of
the type I interferon pathway reveals long double-stranded RNA-mediated RNA interference in mammalian
cells. The EMBO Journal 35:2505–2518. DOI: https://doi.org/10.15252/embj.201695086, PMID: 27815315
McFadden MJ, Gokhale NS, Horner SM. 2017. Protect this house: cytosolic sensing of viruses. Current Opinion
in Virology 22:36–43. DOI: https://doi.org/10.1016/j.coviro.2016.11.012, PMID: 27951430
Papadopoulou AS, Dooley J, Linterman MA, Pierson W, Ucar O, Kyewski B, Zuklys S, Hollander GA, Matthys P,
Gray DHD, De Strooper B, Liston A. 2012. The thymic epithelial microRNA network elevates the threshold for
infection-associated thymic involution via miR-29a mediated suppression of the IFN-a receptor. Nature
Immunology 13:181–187. DOI: https://doi.org/10.1038/ni.2193
Peaston AE, Evsikov AV, Graber JH, de Vries WN, Holbrook AE, Solter D, Knowles BB. 2004. Retrotransposons
regulate host genes in mouse oocytes and preimplantation embryos. Developmental Cell 7:597–606.
DOI: https://doi.org/10.1016/j.devcel.2004.09.004, PMID: 15469847
Rice GI, Del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, Bader-Meunier B, Baildam EM,
Battini R, Beresford MW, Casarano M, Chouchane M, Cimaz R, Collins AE, Cordeiro NJ, Dale RC, Davidson JE,
De Waele L, Desguerre I, Faivre L, et al. 2014. Gain-of-function mutations in IFIH1 cause a spectrum of human
disease phenotypes associated with upregulated type I interferon signaling. Nature Genetics 46:503–509.
DOI: https://doi.org/10.1038/ng.2933, PMID: 24686847
Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, Han H, Liang G, Jones PA, Pugh TJ, O’Brien C,
De Carvalho DD. 2015. DNA-Demethylating agents target colorectal cancer cells by inducing viral mimicry by
endogenous transcripts. Cell 162:961–973. DOI: https://doi.org/10.1016/j.cell.2015.07.056, PMID: 26317465
Witteveldt et al. eLife 2019;8:e44171. DOI: https://doi.org/10.7554/eLife.44171 18 of 19
Research article Chromosomes and Gene Expression Stem Cells and Regenerative Medicine
Scaduto RC, Grotyohann LW. 1999. Measurement of mitochondrial membrane potential using fluorescent
rhodamine derivatives. Biophysical Journal 76:469–477. DOI: https://doi.org/10.1016/S0006-3495(99)77214-0,
PMID: 9876159
Schafer SL, Lin R, Moore PA, Hiscott J, Pitha PM. 1998. Regulation of type I interferon gene expression by
interferon regulatory factor-3. Journal of Biological Chemistry 273:2714–2720. DOI: https://doi.org/10.1074/
jbc.273.5.2714, PMID: 9446577
Tang F, Hajkova P, Barton SC, Lao K, Surani MA. 2006. MicroRNA expression profiling of single whole embryonic
stem cells. Nucleic Acids Research 34:e9. DOI: https://doi.org/10.1093/nar/gnj009, PMID: 16434699
Treiber T, Treiber N, Meister G. 2018. Regulation of microRNA biogenesis and its crosstalk with other cellular
pathways. Nature Reviews. Molecular Cell Biology 1:5–20. DOI: https://doi.org/10.1038/s41580-018-0059-1.
Tsai K, Courtney DG, Kennedy EM, Cullen BR. 2018. Influenza A virus-derived siRNAs increase in the absence of
NS1 yet fail to inhibit virus replication. RNA 24:1172–1182. DOI: https://doi.org/10.1261/rna.066332.118,
PMID: 29903832
van der Veen AG, Maillard PV, Schmidt JM, Lee SA, Deddouche-Grass S, Borg A, Kjær S, Snijders AP, Reis e
Sousa C. 2018. The RIG-I-like receptor LGP2 inhibits Dicer-dependent processing of long double-stranded RNA
and blocks RNA interference in mammalian cells. The EMBO Journal 37:e97479. DOI: https://doi.org/10.
15252/embj.201797479, PMID: 29351913
Wan S, Ashraf U, Ye J, Duan X, Zohaib A, Wang W, Chen Z, Zhu B, Li Y, Chen H, Cao S. 2016. MicroRNA-22
negatively regulates poly(I:c)-triggered type I interferon and inflammatory cytokine production via targeting
mitochondrial antiviral signaling protein (MAVS). Oncotarget 7:12395. DOI: https://doi.org/10.18632/
oncotarget.12395
Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. 2007. DGCR8 is essential for microRNA biogenesis and
silencing of embryonic stem cell self-renewal. Nature Genetics 39:380–385. DOI: https://doi.org/10.1038/
ng1969, PMID: 17259983
Wang R, Wang J, Paul AM, Acharya D, Bai F, Huang F, Guo YL. 2013. Mouse embryonic stem cells are deficient
in type I interferon expression in response to viral infections and double-stranded RNA. Journal of Biological
Chemistry 288:15926–15936. DOI: https://doi.org/10.1074/jbc.M112.421438, PMID: 23580653
Wang R, Wang J, Acharya D, Paul AM, Bai F, Huang F, Guo Y-L. 2014Antiviral Responses in Mouse Embryonic
Stem Cells. Journal of Biological Chemistry 289:25186–25198. DOI: https://doi.org/10.1074/jbc.M113.537746
Witteveldt J, Ivens A, Macias S. 2018. Inhibition of microprocessor function during the activation of the type I
interferon response. Cell Reports 23:3275–3285. DOI: https://doi.org/10.1016/j.celrep.2018.05.049, PMID: 2
9898398
Wu X, Robotham JM, Lee E, Dalton S, Kneteman NM, Gilbert DM, Tang H. 2012. Productive hepatitis C virus
infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during
differentiation. PLOS Pathogens 8:e1002617. DOI: https://doi.org/10.1371/journal.ppat.1002617, PMID: 224
96645
Wu X, Dao Thi VL, Huang Y, Billerbeck E, Saha D, Hoffmann HH, Wang Y, Silva LAV, Sarbanes S, Sun T, Andrus L,
Yu Y, Quirk C, Li M, MacDonald MR, Schneider WM, An X, Rosenberg BR, Rice CM. 2018. Intrinsic immunity
shapes viral resistance of stem cells. Cell 172:423–438. DOI: https://doi.org/10.1016/j.cell.2017.11.018,
PMID: 29249360
Yang Q, Lin J, Liu M, Li R, Tian B, Zhang X, Xu B, Liu M, Zhang X, Li Y, Shi H, Wu L. 2016. Highly sensitive
sequencing reveals dynamic modifications and activities of small RNAs in mouse oocytes and early embryos.
Science Advances 2:e1501482. DOI: https://doi.org/10.1126/sciadv.1501482, PMID: 27500274
Yin Y, Zhou L, Yuan S. 2018. Enigma of retrotransposon biology in mammalian early embryos and embryonic
stem cells. Stem Cells International 2018:1–6. DOI: https://doi.org/10.1155/2018/6239245
Zhao B, Yang D, Jiang J, Li J, Fan C, Huang M, Fan Y, Jin Y, Jin Y. 2014. Genome-wide mapping of miRNAs
expressed in embryonic stem cells and pluripotent stem cells generated by different reprogramming strategies.
BMC Genomics 15:488. DOI: https://doi.org/10.1186/1471-2164-15-488, PMID: 24942538
Witteveldt et al. eLife 2019;8:e44171. DOI: https://doi.org/10.7554/eLife.44171 19 of 19
Research article Chromosomes and Gene Expression Stem Cells and Regenerative Medicine
